IN8BIO, Inc.
F:6JH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IN8BIO, Inc.
F:6JH
|
US |
|
Kikkoman Corp
OTC:KIKOF
|
JP |
|
Nexgen Energy Ltd
TSX:NXE
|
CA |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
E
|
EnerSys
XMUN:FDN
|
US |
|
Progressive Corp
NYSE:PGR
|
US |
|
R
|
Rush Enterprises Inc
NASDAQ:RUSHB
|
US |
|
A
|
Amphenol Corp
F:XPH
|
US |
|
Genuine Parts Co
NYSE:GPC
|
US |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
DE |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
OTC:AIQUF
|
FR |
|
Amtech Systems Inc
NASDAQ:ASYS
|
US |
|
E
|
EnerSys
SWB:FDN
|
US |
|
WT Microelectronics Co Ltd
TWSE:3036
|
TW |
|
Regency Centers Corp
NASDAQ:REG
|
US |
|
Tapestry Inc
NYSE:TPR
|
US |
Bankruptcy Probability
IN8BIO, Inc.'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IN8BIO, Inc. Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
13.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IN8BIO, Inc.'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IN8BIO, Inc. has no debt.
You can find a full breakdown on its Balance Sheet.
